POST Online Media Lite Edition



 

EU OK with $3.9 billion P&G deal for Merck's consumer health business

Staff Writer |
EU antitrust regulators have approved Procter & Gamble’s 3.4 billion euro ($3.9 billion) acquisition of Merck KGaA’s consumer health unit, saying that they had no competition concerns.

Article continues below




The takeover would add vitamin brands such as Seven Seas to a P&G portfolio that includes Pampers diapers and Gillette razors while boosting its presence in Latin America and Asian markets.

The sector has undergone a wave of consolidation in recent years as companies bulk up product ranges and businesses in other markets, but the European Commission said that a preliminary review of the deal found no serious issues.

“The transaction gives rise to a limited number of horizontal overlaps for which the Commission found, following its market investigation, that sufficient competition will remain after the transaction,” the Commission said in a statement.


What to read next

Blackstone launches $5.5 billion Thomson Reuters’ division bridge loan
NXP to repurchase $5 billion shares after Qualcomm deal falls
Delivery Hero jumps on debut in boost for tech IPOs